Company Overview and News

 
Top Ranked Growth Stocks to Buy for April 19th

35m zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 19th:

 
The Zacks Analyst Blog Highlights: America's Car-Mart, Lithia Motors, At Home Group, Dine Brands Global and Urban Outfitters

1h zacks
Chicago, IL – April 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include America's Car-Mart, Inc. (CRMT - Free Report) , Lithia Motors, Inc. (LAD - Free Report) , At Home Group Inc. (HOME - Free Report) , Dine Brands Global, Inc.

 
5 Top Stocks to Buy as Americans Go on a Spending Spree

16h investorplace
Americans have started to splurge on discretionary items after a ho-hum winter season. This is well reflected in the pickup in retailers’ March sales, putting an end to three straight months of a decline. Consumer outlays rose on the back of a strong jobs market, rise in income, tax cuts and refunds. Consumer optimism, by the way, continues to remain at a high level.

 
URBN / Urban Outfitters, Inc. DEFR14A-URBAN OUTFITTERS INC

19h sec.gov
DEFR14A-URBAN OUTFITTERS INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
URBN / Urban Outfitters, Inc. DEFA14A-URBAN OUTFITTERS INC

19h sec.gov
DEFA14A-URBAN OUTFITTERS INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
New Strong Buy Stocks for April 18th

22h zacks
China Telecom Corporation Limited (CHA - Free Report) : This company that provides wireline and mobile telecommunications services has seen the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.

 
5 Top Stocks to Buy as Americans Go on a Spending Spree

2018-04-18 zacks
Americans have started to splurge on discretionary items after a ho-hum winter season. This is well reflected in the pickup in retailers’ March sales, putting an end to three straight months of a decline. Consumer outlays rose on the back of a strong jobs market, rise in income, tax cuts and refunds. Consumer optimism, by the way, continues to remain at a high level.

 
Top Ranked Growth Stocks to Buy for April 17th

2018-04-17 zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 17th:

 
Gap (GPS) Embraces Growth Initiatives to Counter Competition

2018-04-17 zacks
It is unlikely to escape the roller-coaster ride that the U.S. market has undergone lately, thanks to the concerns regarding a trade-war with China, the outcomes of the recent attack on Syria and anticipation of rate hikes by the Fed. During this time, we find The Gap Inc. (GPS - Free Report) as a stock that has shown relative stability and is a safe haven supported by its long-term earnings growth rate of 8%.

 
Top Ranked Growth Stocks to Buy for April 16th

2018-04-16 zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 16th:

 
Scoop Up These 4 Retail Stocks Poised to See a Blockbuster Q1

2018-04-11 zacks
Earnings season is all set to gather momentum and its time you look beyond U.S.-China trade dispute, Facebook data breach and apprehensions about three or more rate hikes by the Fed this year. Given strong economic fundamentals and lower corporate tax rate, the reporting cycle is likely to be a favorable one. Notably, per the latest Earnings Outlook, total earnings for the S&P 500 index is expected to rise 16% in the first quarter of 2018 versus 13.

 
Nordstrom Launches First Full-Line Men's Store in New York

2018-04-10 zacks
Nordstrom, Inc.’s (JWN - Free Report) first-ever exclusive men's store in New York City is slated to open doors near Manhattan’s Columbus Circle on Apr 12. This 47,000 square feet store is a prelude to the company’s largest store project, which together with a standalone women's store is expected to become an important shopping destination. The women’s store is scheduled to open in fall 2019. Notably, the aforementioned full-line stores together will make one of the largest and most important fashion market hubs in New York.

 
New Blink Electric Vehicle Charging Stations Installed at Aventura Mall, Aventura Florida

2018-04-10 globenewswire
Aventura, Florida, April 10, 2018 (GLOBE NEWSWIRE) -- Leading owner, operator, and provider of electric vehicle (EV) charging hardware and services, Blink Charging Co. (NASDAQ: BLNK, BLNKW) (“Blink Charging” or the “Company”), announced that it has installed EV charging stations at Aventura Mall in Aventura, Florida. The units were installed in the Nordstrom and Bloomingdale’s parking garages, offering EV charging options near two of the mall’s anchor stores.

 
Lululemon seeks new CEO with cultural fit and squeaky clean image

2018-04-09 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 917047102